FdaApplication

NDA 206544

Back to search

Identifiers

Properties

PropertyValue
applicant_nameOHEMO LIFE SCIENCES INC
application_typeNDA
approval_date2015-10-02

Products (4)

ProductActive ingredientStrengthDosage form
MORPHABOND ERMORPHINE SULFATE15MGTABLET, EXTENDED RELEASE;ORAL
MORPHABOND ERMORPHINE SULFATE60MGTABLET, EXTENDED RELEASE;ORAL
MORPHABOND ERMORPHINE SULFATE100MGTABLET, EXTENDED RELEASE;ORAL
MORPHABOND ERMORPHINE SULFATE30MGTABLET, EXTENDED RELEASE;ORAL

4 products